Physician profile
John M Hale
NPI 1447229760
$3,405.74
in general payments reported to CMS, 2019-2025
13 companies · $1,722 in 2025
The $1,722 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $227 · 2022: $1,017 · 2023: $214 · 2024: $226 · 2025: $1,722.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,073 · Travel and Lodging: $1,043 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,073.27 |
| Travel and Lodging | $1,043.49 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,655.07 | 2021-2025 | Synchromedii, Inceptiv, Intellis Adaptivestim |
| Abbott Laboratories | $218.06 | 2023-2025 | Eterna |
| Abbvie INC. | $172.09 | 2023-2025 | |
| W. L. Gore & Associates, INC. | $90.83 | 2021-2022 | |
| Stimwave Technologies Incorporated | $56.00 | 2021 | |
| Globus Medical, INC. | $53.28 | 2025 | Senza |
| Nevro Corp. | $35.68 | 2024 | Senza |
| Si-Bone, INC. | $26.63 | 2025 | |
| Boston Scientific Corporation | $24.43 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.42 | 2024 | Relistor |
| Lilly USA, LLC | $17.48 | 2023 | Reyvow, Emgality |
| Valinor Pharma, LLC | $16.67 | 2024 | Movantik |
| Tonix Medicines, INC. | $16.10 | 2025 | Tonmya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.